Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bf863fc99dacfcca6fe34bba0729b420e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bf863fc99dacfcca6fe34bba0729b420e NCIT_P378 "NCI" @default.
- Bf863fc99dacfcca6fe34bba0729b420e type Axiom @default.
- Bf863fc99dacfcca6fe34bba0729b420e annotatedProperty IAO_0000115 @default.
- Bf863fc99dacfcca6fe34bba0729b420e annotatedSource NCIT_C172999 @default.
- Bf863fc99dacfcca6fe34bba0729b420e annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with dabrafenib and trametinib in patients with tumors that have BRAF V600E or V600K substitution mutations, excluding colorectal cancer, melanoma, non-small cell lung cancer, or thyroid cancer." @default.